Effects of Lipopolysaccharide on the Blood-Brain Barrier Permeability in Prolonged Nitric Oxide Blockade-Induced Hypertensive Rats

REFERENCES

• Abbott N. J. Astrocyte-endothelia interactions and blood-brain barrier permeability. Journal of Anatomy 2002; 200: 629–638
   PubMed Web of Science ®Google Scholar
• Akao S., Kiumi F. The tight junction of main pancreatic duct epithelial cells is a morphometrically dynamic structure altered by intraductal hypertension. Medical Electron Microscopy 2002; 45: 146–152, [CROSSREF]
   Google Scholar
• Albrecht E. W., Stegeman C. A., Heeringa P., Henning R. H., van Goor H. Protective role of endothelial nitric oxide synthase. Journal of Pathology 2003; 199: 8–17, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Banks W. A., Kastin A. J. The interleukins-1 alpha, -1 beta, and -2 do not acutely disrupt the murine blood-brain barrier. International Journal of Immunopharmacology 1992; 14: 629–636, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Bastide M., Gele P., Petrault O., Pu Q., Caliez A., Robin E., Deplanque D., Duriez P., Bordet R. Delayed cerebrovascular protective effect of lipopolysaccharide in parallel to brain ischemic tolerance. Journal of Cerebral Blood Flow and Metabolism 2003; 23: 399–405
   PubMedGoogle Scholar
• Bernard C., Merval R., Esposito B., Tedgui A. Resistance to endotoxin shock in spontaneously hypertensive rats. Hypertension 1998; 31: 1350–1356
   PubMedGoogle Scholar
• Beutler H. O., Wurst B., Fischer S. Eine neue Methode zur enzymatishcen Bestimmung von Nitrat in Lebensmitteln. Deutsche Lebensmittel-Rundschau 1996; 82: 283–289
   Google Scholar
• Bickel U., Grave B., Kang Y. S., del Rey A., Voigt K. No increase in blood-brain barrier permeability after intraperitoneal injection of endotoxin in the rat. Journal of Neuroimmunology 1998; 85: 131–136, [CROSSREF]
   PubMedGoogle Scholar
• Blamire A. M., Anthony D. C., Rajagopalan B., Sibson N. R., Perry V. H., Styles P. Interleukin-1beta-induced changes in blood-brain barrier permeability, apparent diffusion coefficient, and cerebral blood volume in the rat brain: A magnetic resonance study. Journal of Neuroscience 2000; 20: 8153–8159
   PubMed Web of Science ®Google Scholar
• Chen J., Simon R. Ischemic tolerance in the brain. Neurology 1997; 48: 306–311
   PubMed Web of Science ®Google Scholar
• Descamps L., Coisne C., Dehouck B., Cecchelli R., Torpier G. Protective effect of glial cells against lipopolysaccharide-mediated blood-brain barrier injury. Glia 2003; 42: 46–58, [CROSSREF]
   PubMedGoogle Scholar
• Gaillard P. J., de Boer A. B. G., Breimer D. D. Pharmacological investigations on lipopolysaccharide-induced permeability changes in the blood-brain barrier in vitro. Microvascular Research 2003; 65: 24–31, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Hen L. M., Yong V. W. Interleukin-1 beta is required for the early evolution of reactive astrogliosis following CNS lesion. Journal of Neuropathology and Experimental Neurology 2001; 60: 961–71
   PubMedGoogle Scholar
• Johansson B. B. Hypertension. The introduction to the blood-brain barrier. Methodology, biology and pathology, W. M. Pardridge. Cambridge University Press, Cambridge 1998; 427–433
   Google Scholar
• Kaya M., Chang L., Truong A., Brightman M. Chemical induction of fenestrae in vessels of the blood-brain barrier. Experimental Neurology 1996; 142: 6–13, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Kaya M., Kalayci R., Küçük M., Arican N., Elmas I., Kudat H., Korkut F. Effect of losartan on the blood-brain barrier permeability in diabetic hypertensive rats. Life Sciences 2003; 73: 3235–3244, [CROSSREF]
   PubMedGoogle Scholar
• Krizanac-Bengez L., Kapural M., Parkinson F., Cucullo L., Hossain M., Mayberg M. R., Janigro D. Effects of transient loss of shear stress on blood-brain barrier endothelium: Role of nitric oxide and IL-6. Brain Research 2003; 977: 961–971, [CROSSREF]
   Google Scholar
• Liedtke W., Edelmann W., Bieri P. L., Chiu F. C., Cowan N. J., Kucherlapati R., Raine C. S. GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron 1996; 17: 607–615, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Lippoldt A., Kniesel U., Liebner S., Kalbacher H., Kirsch T., Wolburg H., Haller H. Structural alterations of tight junctions are associated with loss of polarity in stroke-prone spontaneously hypertensive rat blood-brain barrier endothelial cells. Brain Research 2000; 885: 251–261, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Mayhan W. G. Role of nitric oxide in disruption of the blood-brain barrier during acute hypertension. Brain Research 1995; 686: 99–103, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Mayhan W. G. Effect of lipopolysaccharide on the permeability and reactivity of the cerebral microcirculation: role of inducible nitric oxide synthase. Brain Research 1998; 792: 353–357, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Mayhan W. G. Inhibition of nitric oxide synthase does not alter permeability of the blood-brain barrier. Brain Research 2000; 855: 143–149, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Mayhan W. G. Cellular mechanisms by which tumor necrosis factor-a produces disruption of the blood-brain barrier. Brain Research 2002; 927: 144–152, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Nedrebo T., Reed R. K. Different serotypes of endotoxin (lipopolysaccharide) cause different increases in albumin extravasation in rats. Shock 2002; 18: 138–141, [CROSSREF]
   PubMedGoogle Scholar
• Papadopoulos M. C., Saadoun S., Woodrow C. J., Davies D. C., Costa-Martins P., Moss R. F., Krishna S., Bell B. A. Occludin expression in microvessels of neoplastic and non-neoplastic human brain. Neuropathology and Applied Neurobiology 2001; 27: 184–195, [CROSSREF]
   Google Scholar
• Paul R., Koedel U., Winkler F., Kieseier B. C., Fontana A., Kopf M., Hartung H. P., Pfister H. W. Lack of IL-6 augments inflammatory response but decreases vascular permeability in bacterial meningitis. Brain 2003; 126: 1873–1882, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Prado R., Watson B. D., Kuluz J., Dietrich W. D. Endothelium-derived nitric oxide synthase inhibition. Effects on cerebral blood flow, pial artery diameter, and vascular morphology in rats. Stroke 1992; 23: 1118–1124
   PubMed Web of Science ®Google Scholar
• Rumbaut R. E., McKay M. K., Huxley V. H. Capillary hydraulic conductivity is decreased by nitric oxide synthase inhibition. American Journal of Physiology 1995; 268: H1856–H1861
   PubMedGoogle Scholar
• Rumbaut R. E., Huxley V.H. Similar permeability responses to nitric oxide synthase inhibitors of venules from three animal species. Microvascular Research 2002; 64: 21–31, [CROSSREF]
   PubMedGoogle Scholar
• Shyamaladevi N., Jayakumar A. R., Sujatha R., Paul V., Subramanian E. H. Evidence that nitric oxide production increases gamma-amino butyric acid permeability of blood-brain barrier. Brain Research Bulletin 2002; 57: 231–236, [CROSSREF]
   PubMedGoogle Scholar
• Tasaki K., Ruetzler C. A., Ohtsuki T., Martin D., Nawashiro H., Hallenbeck J. M. Lipopolysaccharide pre-treatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Research 1997; 748: 267–270, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Wespelwey B., Jesse A. J., Hansen E. J., Scheld W. M. Haemophilus influenzae lipopolysaccharide-induced blood brain barrier permeability during experimental meningitis in the rat. Journal of Clinical Investigation 1988; 82: 1339–1346
   PubMedGoogle Scholar
• West M. A., Heagy W. Endotoxin tolerance: A review. Critical Care Medicine 2002; 30: S64–S73, [CROSSREF]
   Web of Science ®Google Scholar
• Wu C. C., Hong H. J., Chou T. C., Ding Y. A., Yen M. H. Evidence for inducible nitric oxide synthase in spontaneously hypertensive rats. Biochemical and Biophysical Research Communications 1996; 228: 459–466, [CROSSREF]
   PubMedGoogle Scholar
• Xaio H., Banks W. A., Niehoff M. L., Morley J. E. Effect of LPS on the permeability of the blood-brain barrier to insulin. Brain Research 2001; 896: 36–42, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Zhao Q., Egashira K., Inoue S., Usui M., Kitamoto S., Ni W., Ishibashi M., Hiasa K., Ichiki T., Shibuya M., Takeshita A. Vascular endothelial growth factor is necessary in the development of arteriosclerosis by recruiting/activating monocytes in a rat model of long-term inhibition of nitric oxide synthesis. Circulation 2002; 105: 1110–1115, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Zielasek J., Hartung H. P. Molecular mechanisms of microglial activation. Advances in Neuroimmunology 1996; 6: 191–222
   PubMedGoogle Scholar